Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Clinical Services Laboratory, |
RCV000001905 | SCV000915984 | pathogenic | Senior-Loken syndrome 5 | 2017-04-28 | criteria provided, single submitter | clinical testing | The IQCB1 c.424_425delTT (p.Phe142ProfsTer5) variant is a frameshift variant that is predicted to result in premature termination of the protein. The p.Phe142ProfsTer5 variant has been reported in three studies in which it is found in a total of nine individuals with Senior Loken syndrome, including in seven patients in a homozygous state and in two patients in a compound heterozygous state who both carried a null variant on the second allele (Otto et al. 2005; Estrada-Cuzcano et al. 2011; Halbritter et al. 2013). The p.Phe142ProfsTer5 variant was absent from 347 control subjects but is reported at a frequency of 0.00023 in the European (non-Finnish) population of the Exome Aggregation Consortium. Based on the evidence, the p.Phe142ProfsTer5 variant is classified as pathogenic for Senior Loken syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Invitae | RCV000822567 | SCV000963376 | pathogenic | Nephronophthisis | 2019-12-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe142Profs*5) in the IQCB1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs750962965, ExAC 0.02%). This variant has been reported in individuals affected with Leber congenital amaurosis and Senior-L ken syndrome (PMID: 23188109, 15723066, 28832562, 21866095, 20881296, 24625443, 28041643). This variant is also known as c.224_225delTT, p.F142fsX146 in the literature. ClinVar contains an entry for this variant (Variation ID: 1831). Loss-of-function variants in IQCB1 are known to be pathogenic (PMID: 15723066, 21866095). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001073766 | SCV001239326 | pathogenic | Retinal dystrophy | 2017-12-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001093170 | SCV001250020 | pathogenic | not provided | 2018-05-01 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000001905 | SCV000022063 | pathogenic | Senior-Loken syndrome 5 | 2011-02-11 | no assertion criteria provided | literature only | |
NIHR Bioresource Rare Diseases, |
RCV000505085 | SCV000598854 | pathogenic | Leber congenital amaurosis | 2015-01-01 | no assertion criteria provided | research | |
Human Genetics - |
RCV000001905 | SCV000804661 | pathogenic | Senior-Loken syndrome 5 | 2016-09-01 | no assertion criteria provided | clinical testing |